Search

everythinglearnresearchcommunity

for

Search:↓

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Targeting ATM could help manage heart cell enlargement due to pressure overload.

Biological therapy boosts the immune system to effectively fight melanoma.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Axitinib treatment turned a man's grey hair back to black.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

Increasing m6A levels can improve skin cell growth and wound healing.

A new metformin-based treatment may effectively promote hair growth with fewer side effects.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.